StockTipsArenaBeta

Gland Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,850.4-84.60 (-2.88%)

Avg 1-year target

6 of 8 long-term calls BUY

₹3,201.8812.3% above today's price

Gland Pharma's average 1-year share price target is ₹3,201.88, the average of 8 advisors' latest targets. Targets range from ₹2,125 to ₹4,200.

Latest: Nomura India Research ₹3,750 · 7 Oct 2026

12
10 BUY · 2 SELL, all horizons
8
with an active 1Y target
38%
15 of 40 closed calls hit
52
all horizons, open and closed
Watch GLAND for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Gland Pharma target price by brokerage

Each advisor's latest 1-year target · 8 advisors · tap a row for the call

All tips (52)

BUYTarget₹3,750
NIbyNomura India Research+31.6% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹3,026 · via CNBC Awaaz.P&L -5.8%
BUYTarget₹3,430
ISbyICICI Securities+20.3% to target
1 Year* · 12 mo left · 5 Oct 2026 · entry ₹2,911.5 · via Institutional / Brokerage ResearchP&L -2.1%
BUYTarget₹3,300
RPbyRajesh Palviya, Axis Securities+15.8% to target
1 Year · 10 mo left · 25 Aug 2026 · entry ₹2,795.2 · via ET NowP&L +2.0%
SELLTarget₹2,260
CbyCitigroup+20.7% to target
1 Year* · 10 mo left · 12 Aug 2026 · entry ₹2,881.2 · via ET Now (Live)P&L +1.1%
BUYTarget₹4,200
NWbyNuvama Wealth+47.3% to target
1 Year* · 10 mo left · 12 Aug 2026 · entry ₹2,924 · via ET Now (Live)P&L -2.5%
BUYTarget₹3,200
ADbyAamar Deo Singh, Angel One+12.3% to target
1 Year* · 10 mo left · 11 Aug 2026 · entry ₹2,876 · via CNBC Awaaz.P&L -0.9%
SELLTarget₹2,125
GSbyGoldman Sachs+25.4% to target
1 Year* · 10 mo left · 11 Aug 2026 · entry ₹2,845.5 · via ET Now (Live)P&L -0.2%
BUYTarget₹3,350
JIbyJefferies India+17.5% to target
1 Year* · 10 mo left · 11 Aug 2026 · entry ₹2,845.5 · via Zee Business (Live)P&L +0.2%
BUYTarget₹3,080
MObyMotilal OswalTarget hit
1 Year* · 11 Aug 2026 · entry ₹2,845.5 · via ET Now (Live)exit ₹3,080
BUYTarget₹3,000
AJbyAnsh Jogendra BhilwarTarget hit
1 Year* · 11 Aug 2026 · entry ₹2,845.5 · via Zee Business (Live)exit ₹3,000
BUYTarget₹2,645
ISbyICICI SecuritiesTarget hit
1 Year* · 22 May 2026 · entry ₹2,334 · via Institutional / Brokerage Researchexit ₹2,645
BUYTarget₹2,170
ASbyAxis SecuritiesTarget hit
1 Year* · 29 Jan 2026 · entry ₹1,800.1 · via Institutional / Brokerage Researchexit ₹2,170
BUYTarget₹2,275
ISbyICICI SecuritiesTarget hit
1 Year* · 29 Jan 2026 · entry ₹1,800.1 · via Institutional / Brokerage Researchexit ₹2,275
BUYTarget₹2,050
MObyMotilal OswalTarget hit
1 Year* · 28 Jan 2026 · entry ₹1,689.7 · via Institutional / Brokerage Researchexit ₹2,050
BUYTarget₹2,270
ISbyICICI SecuritiesTarget hit
1 Year* · 4 Nov 2025 · entry ₹1,911.8 · via Institutional / Brokerage Researchexit ₹2,270
BUYTarget₹2,310
MObyMotilal OswalTarget hit
1 Year* · 4 Nov 2025 · entry ₹1,911.8 · via Institutional / Brokerage Researchexit ₹2,310
BUYTarget₹2,340
MObyMotilal OswalTarget hit
1 Year* · 6 Aug 2025 · entry ₹1,957.5 · via Institutional / Brokerage Researchexit ₹2,340
BUYTarget₹1,840
MObyMotilal OswalTarget hit
1 Year* · 3 Feb 2025 · entry ₹1,513.95 · via Institutional / Brokerage Researchexit ₹1,840
BUYTarget₹2,440
MObyMotilal OswalExpired
1 Year* · 6 Aug 2024 · entry ₹2,106.95 · via Institutional / Brokerage Researchexit ₹1,957.5
BUYTarget₹3,400
VKbyVishnu Kant Upadhyay, Master Capital Services+19.3% to target
1–3 Months · 3 mo left · 13 Oct 2026 · entry ₹3,078.4 · via LiveMint MarketsP&L -7.4%
BUYTarget₹3,220
ISbyICICI Securities+13.0% to target
1–3 Months* · 7 wk left · 7 Sept 2026 · entry ₹2,940 · via Economic Times New Stock RecosP&L -3.0%
BUYTarget₹3,300
ABbyAkshay Bhagwat, JM Financial+15.8% to target
1–3 Months* · 4 wk left · 19 Aug 2026 · entry ₹2,839.4 · via Business TodayP&L +0.4%
BUYTarget₹3,250
PHbyPradeep Haldar, PHD Capital+14.0% to target
1–3 Months · 17h left · 24 Jul 2026 · entry ₹2,384.8 · via Business TodayP&L +19.5%
BUYTarget₹2,500
VRbyVinay Rajani, HDFC SecuritiesTarget hit
1–3 Months* · 30 Jun 2026 · entry ₹2,371.9 · via NDTV Profit (Live)exit ₹2,500
BUYTarget₹2,675
RVbyRaja VenkatramanTarget hit
1–3 Months · 25 Jun 2026 · entry ₹2,330 · via LiveMint Marketsexit ₹2,675
BUYTarget₹3,000
AAbyAditya Agarwal, Coheron BrokersTarget hit
1–3 Months* · 20 May 2026 · entry ₹2,221.8 · via Business Todayexit ₹3,000
BUYTarget₹3,325
RVbyRaja VenkatramanStop-loss hit
1–3 Months · 7 Oct 2026 · entry ₹3,010 · via LiveMint Buy-or-Sell (topic)exit ₹2,910
BUYTarget₹3,100
RBbyRakesh BansalStop-loss hit
1–3 Months* · 7 Jul 2026 · entry ₹2,517.1 · via Zee Business (Live)exit ₹2,400
BUYTarget₹3,300
RBbyRakesh BansalExpired
1–3 Months* · 23 Jun 2026 · entry ₹2,251 · via Zee Business (Live)exit ₹2,916.6
BUYTarget₹3,060
ASbyAmit SethTarget hit
1–2 Weeks* · 6 Oct 2026 · entry ₹3,026 · via CNBC Awaaz.exit ₹3,060
BUYTarget₹2,720
SBbySumeet Bagadia, Choice BrokingTarget hit
1–2 Weeks* · 30 Jul 2026 · entry ₹2,544 · via LiveMint Buy-or-Sell (topic)exit ₹2,720
BUYTarget₹3,200
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 7 Oct 2026 · entry ₹3,150.6 · via CNBC Awaaz.exit ₹3,100
BUYTarget₹3,220
SBbySumeet Bagadia, Choice BrokingStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹2,990 · via LiveMint Marketsexit ₹2,870
BUYTarget₹3,200
NCbyNirav Chheda, Nirmal Bang SecuritiesStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹3,011 · via CNBC Awaaz.exit ₹2,910
BUYTarget₹3,150
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹2,997 · via IDBI Capital Research Calls Telegramexit ₹2,907
BUYTarget₹3,200
SCbyShrikant Chouhan, Kotak SecuritiesStop-loss hit
1–2 Weeks* · 10 Sept 2026 · entry ₹3,031 · via NDTV Profitexit ₹2,850
BUYTarget₹3,120
CTbyChandan Taparia, Motilal OswalStop-loss hit
1–2 Weeks* · 9 Sept 2026 · entry ₹2,997 · via CNBC Awaaz.exit ₹2,940
BUYTarget₹3,070
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 31 Aug 2026 · entry ₹2,905 · via IDBI Capital Research Calls Telegramexit ₹2,831
BUYTarget₹2,600
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 29 Jul 2026 · entry ₹2,535.5 · via CNBC Awaaz.exit ₹2,500
BUYTarget₹2,600
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 16 Jul 2026 · entry ₹2,493.5 · via ET Now (Live)exit ₹2,420
BUYTarget₹2,950
PHbyPradip Hotchandani, Prudent Corporate Advisory ServicesStop-loss hit
1–2 Weeks* · 16 Jul 2026 · entry ₹2,550 · via CNBC Awaaz.exit ₹2,478
BUYTarget₹2,650
SCbyShrikant Chouhan, Kotak SecuritiesStop-loss hit
1–2 Weeks* · 16 Jul 2026 · entry ₹2,520 · via CNBC Awaaz.exit ₹2,480
BUYTarget₹2,600
ABbyAshish Bahety, Profitmart SecuritiesStop-loss hit
1–2 Weeks* · 7 Jul 2026 · entry ₹2,520.8 · via CNBC Awaaz.exit ₹2,480
BUYTarget₹2,400
SSbySudeep Shah, SBICAP SecuritiesStop-loss hit
1–2 Weeks* · 11 Jun 2026 · entry ₹2,329.8 · via Zee Business (Live)exit ₹2,280
BUYTarget₹3,210
ICbyIDBI CapitalExpired
1–2 Weeks* · 6 Oct 2026 · entry ₹3,002 · via IDBI Capital Research Calls Telegramexit ₹3,014
BUYTarget₹2,900
AJbyAnshul Jain, Lakshmishree Investment and SecuritiesExpired
1–2 Weeks* · 8 Jul 2026 · entry ₹2,545.3 · via Business Todayexit ₹2,485.5
BUYTarget₹2,700
AJbyAnshul Jain, Lakshmishree Investment and SecuritiesExpired
1–2 Weeks* · 1 Jul 2026 · entry ₹2,445.6 · via Business Todayexit ₹2,493.2
BUYTarget₹3,100
CTbyChandan Taparia, Motilal OswalStop-loss hit
BTST · 9 Sept 2026 · entry ₹3,026.2 · via CNBC Awaaz.exit ₹2,980
BUYTarget₹3,000
CTbyChandan Taparia, Motilal OswalExpired
BTST · 26 Aug 2026 · entry ₹2,903.2 · via CNBC Awaaz.exit ₹2,871.4
BUYTarget₹3,070
SRbySiddharth Rai MangalaStop-loss hit
Intraday* · 30 Sept 2026 · entry ₹2,990 · via Zee Business (Live)exit ₹2,955

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks